Identification of T cell and linear B cell epitopes on African horse sickness virus serotype 4 proteins VP1-1, VP2, VP4, VP7 and NS3.

Overview

• This research identifies specific parts (epitopes) of African horse sickness virus serotype 4 (AHSV4) proteins that are recognized by horse immune cells, potentially aiding the development of improved vaccines.

Background and Purpose

• African horse sickness virus (AHSV) is a fatal viral disease affecting horses, and serotype 4 (AHSV4) is one of its variants.
• Understanding the immune response to the virus’s proteins can help develop better vaccines and treatments.
• Previous research had established that the viral proteins VP1-1, VP2, VP4, VP7, and NS3 contain regions recognized by CD8+ T cells, a key immune cell type involved in fighting infections.
• This study aimed to comprehensively map both T cell epitopes (recognized by CD8+ and CD4+ T cells) and linear B cell epitopes on these AHSV4 proteins.

Methods

• Peptides overlapping the full length of each selected viral protein (VP1-1, VP2, VP4, VP7, NS3) were synthesized to systematically cover every possible epitope.
• Peripheral blood mononuclear cells (PBMCs), which include T cells and B cells, were collected from five horses previously immunized with an attenuated AHSV4 vaccine.
• These PBMCs were stimulated in vitro with the synthesized peptides.
• Various memory immune assays were performed to detect the immune responses to specific peptides.
• The assays helped to identify which peptides contained epitopes recognized by CD8+ T cells, CD4+ T cells, or linear B cells (the latter involved in antibody recognition).

Results

• The study successfully identified individual peptides within the VP1-1, VP4, VP7, and NS3 proteins that contain:
  • CD8+ T cell epitopes
  • CD4+ T cell epitopes
  • Linear B cell epitopes
• Notably, peptides from VP2 were not mentioned in the final findings, implicating that no or fewer relevant epitopes were identified from that protein in this context.

Implications and Applications

• Identification of specific T cell and B cell epitopes provides precise targets for designing peptide-based vaccines against AHSV4.
• Such targeted vaccines could focus the immune response on effective viral components, potentially improving vaccine safety and efficacy over traditional attenuated virus vaccines.
• These epitopes might also serve as the basis for novel therapeutic interventions, such as immunotherapies or diagnostic tools for African horse sickness.
• The mapping techniques and findings offer a platform for epitope identification in other serotypes or related viruses.

Summary

• This research advances understanding of the immune interactions between horses and AHSV4 by defining precise viral protein regions that activate T cells and B cells.
• The study’s methodologies combine peptide synthesis and immune assays using cells from immunized animals, highlighting a systematic approach to epitope mapping.
• These insights are crucial for next-generation vaccine development against this economically important equine disease.